好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

GO-SCAN: A Scoring System for Signs and Symptoms of Maternal Stroke
Cerebrovascular Disease and Interventional Neurology
P11 - Poster Session 11 (8:00 AM-9:00 AM)
13-009

To develop a method to help clinicians differentiate stroke from preeclampsia with severe features (PSF) in pregnant and postpartum patients presenting with acute symptoms.

Stroke is a leading cause of maternal morbidity and mortality, but diagnostic delays are common in this population due to maternal stroke’s relative rarity, and symptomatic overlap with other acute pregnancy-related syndromes such as PSF, which commonly presents with neurological symptoms.

We reviewed 71 consecutive cases of pregnant and postpartum patients with confirmed stroke of any type admitted to our academic medical center. Our control group consisted of 102 patients admitted with acute PSF. We compared clinical characteristics and presenting signs and symptoms between the two groups. We then used multivariable logistic regression models to develop a discriminatory score. Score validity was then tested by dividing the same cohort into derivation (n=140) and validation (n=33) datasets. Key variables were used to develop a bedside tool to distinguish acute stroke from PSF. 

Beta coefficients from the multivariable regression model yielding the best c-statistic (0.9) were used to develop the GO-SCAN score, which included Gestational diabetes (-1), Obesity (-1), Sudden headache (+7), Chronic hypertension (-1),  Altered mental status (+2), and Neurological focal deficits (+1).  The score range was −3 to +10. A score of ≥1 had 99% specificity and 54% sensitivity for diagnosing stroke, while a score of ≤-2 had 98% specificity for PSF without stroke. Scores between -1-0 had 27% specificity and 98% sensitivity for distinguishing stroke from PSF. 

Stroke in postpartum patients can be accurately distinguished from PSF using a combination of clinical signs and symptoms as well as patient medical history. The GO-SCAN score may be a useful clinical decision-making tool, but should be validated in larger, multicenter cohorts.

Authors/Disclosures
Catherine G. Shang, MD
PRESENTER
Ms. shang has nothing to disclose.
Minghua Liu Minghua Liu has nothing to disclose.
Noora C. Haghighi, MS Miss Haghighi has nothing to disclose.
Elida Romo, BS Miss Romo has nothing to disclose.
Samantha Jankowski (University of Chicago) No disclosure on file
Raeann Bourscheid, MD (New York Presbyterian - Columbia) Dr. Bourscheid has nothing to disclose.
Whitney A. Booker, MD Dr. Booker has nothing to disclose.
Alison Seitz, MD (New York Presbyterian Hospital) Dr. Seitz has stock in Colgate Palmolive.
Sara Shapouran, MD (Montefiore) Dr. Shapouran has nothing to disclose.
Lauren Mamer (University of Michigan) No disclosure on file
William J. Meurer, MD (University of Michigan) Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Berry Consultants. The institution of Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meurer Consulting. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Emergency Medicine. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Trials Journal . Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Academic Emergency Medicine Journal. Dr. Meurer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Meurer Consulting. The institution of Dr. Meurer has received research support from NIH and AHRQ. Dr. Meurer has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of Grants and FDA submissions with NIH and FDA. Dr. Meurer has a non-compensated relationship as a Member of Board of Directors with Society for Clinical Trials that is relevant to AAN interests or activities.
Ava L. Liberman, MD (Weill Cornell Medicine) Dr. Liberman has nothing to disclose.
Liam Shields, MD Dr. Shields has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American College of Obstetricians & Gynecologists. The institution of Dr. Shields has received research support from AHRQ. Dr. Shields has received intellectual property interests from a discovery or technology relating to health care. Dr. Shields has received publishing royalties from a publication relating to health care.
Jane L. Holl, MD The institution of Dr. Holl has received research support from NIH.
Shyam Prabhakaran, MD (University of Chicago) Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Eliza C. Miller, MD (University of Pittsburgh) Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.